Funder
National Health and Medical Research Council
The University of Queensland
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. Int J Prosthodont 2006; 19: 126–128.
2. Michaeli DT, Yagmur HB, Achmadeev T, Michaeli T. Value drivers of development stage biopharma companies. Eur J Health Econ 2022; 23: 1287–1296.
3. Michaeli DT, Yagmur HB, Achmadeev T, Michaeli T. Valuation and returns of drug development companies: lessons for bioentrepreneurs and investors. Ther Innov Regul Sci 2022; 56: 313–322.
4. Michaeli T, Jürges H, Michaeli DT. FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis. BMJ 2023; 381: e073242.
5. Snowdon C, Kernaghan S, Moretti L, et al. Operational complexity versus design efficiency: challenges of implementing a phase IIa multiple parallel cohort targeted treatment platform trial in advanced breast cancer. Trials 2022; 23: 372.